Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-17.36%
↓ 37% below average
Average (4y)
-12.65%
Historical baseline
Range
High:-0.20%
Low:-41.50%
CAGR
+207.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -17.36% | +58.2% |
| 2023 | -41.50% | -2257.4% |
| 2022 | -1.76% | +28.6% |
| 2021 | -2.47% | -1161.2% |
| 2020 | -0.20% | - |